The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 314.00
Ask: 315.80
Change: -0.40 (-0.13%)
Spread: 1.80 (0.573%)
Open: 307.00
High: 315.40
Low: 307.00
Prev. Close: 314.40
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase programme

26 Feb 2020 10:01

RNS Number : 1893E
Ascential PLC
26 February 2020
 

 

 

 

26 February 2020

 

 

Ascential plc ("the Company")

Share repurchase programme

 

Pursuant to the authority granted at the Annual General Meeting of the Company held on 8 May 2019, the Company announces it entered into a non-discretionary agreement with Numis Securities Limited ("Numis") on 25 February 2020 in relation to the purchase by Numis, acting as principal, of the Company's ordinary shares of 1 pence each ("Ordinary Shares") for an aggregate purchase price of up to £120m (the "Programme") and not exceeding 40,277,568 ordinary shares of 0.01p each, representing approximately 9.99% per cent. of its current issued ordinary share capital.

The Company commenced the buyback programme on Tuesday 25 February 2020.

Any purchase of shares done in relation to this announcement will be carried out on the London Stock Exchange and will be effected within certain pre-set parameters.

Ascential's shareholders generally authorised Ascential to purchase Ordinary Shares at its 2019 Annual General Meeting held on 8 May 2019, subject to certain limitations (the "Authority"). The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the Authority. The Programme will be executed in accordance with (and subject to the limits prescribed by) the Authority and will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and in accordance with Chapter 12 of the Listing Rules.

The Company will announce any market repurchase of shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. The purpose of the Programme is to reduce the share capital of the Company. All Shares purchased will be cancelled.

The total number of voting rights in the Company on 25 February 2020 was 403,274,977.

 

Name and contact details for enquiries:

Louise Meads, Company Secretary +44 (0) 20 7516 5042

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSTFMLTMTATMPM
Date   Source Headline
16th Nov 202311:57 amRNSHolding(s) in Company
6th Nov 20232:46 pmRNSHolding(s) in Company
6th Nov 202312:22 pmRNSHolding(s) in Company
3rd Nov 20232:43 pmRNSHolding(s) in Company
2nd Nov 20233:46 pmRNSHolding(s) in Company
2nd Nov 202310:29 amRNSHolding(s) in Company
1st Nov 20234:18 pmRNSHolding(s) in Company
1st Nov 20231:50 pmRNSHolding(s) in Company
1st Nov 202311:22 amRNSDirector/PDMR Shareholding
31st Oct 20231:12 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSUpdate on investment in Hudson MX
30th Oct 20237:00 amRNSProposed sale of Digital Commerce and WGSN
24th Oct 20237:00 amRNSHolding(s) in Company
16th Oct 202310:23 amRNSHolding(s) in Company
2nd Oct 202311:59 amRNSTotal Voting Rights
22nd Sep 20237:00 amRNSHalf year results
7th Sep 20235:55 pmRNSBoard change
30th Aug 20239:48 amRNSBlock listing application
24th Aug 20234:05 pmRNSBlock listing Interim Review
24th Aug 202311:48 amRNSDirector Declaration
10th Aug 20234:41 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:47 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSNotice of Capital Markets Event
1st Jun 202310:38 amRNSTotal Voting Rights
18th May 202310:46 amRNSResult of AGM
17th Apr 20233:18 pmRNSDirector/PDMR Shareholding
17th Apr 202310:02 amRNSHolding(s) in Company
4th Apr 20236:15 pmRNSHolding(s) in Company
3rd Apr 202311:33 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSFinal Results
23rd Mar 20234:27 pmRNSHolding(s) in Company
20th Mar 20234:50 pmRNSHolding(s) in Company
15th Mar 202312:31 pmRNSHolding(s) in Company
1st Mar 20232:22 pmRNSTotal Voting Rights
24th Feb 202312:38 pmRNSDirector/PDMR Shareholding
20th Feb 202311:12 amRNSDirector/PDMR Shareholding
17th Feb 20233:22 pmRNSHolding(s) in Company
16th Feb 202312:48 pmRNSHolding(s) in Company
7th Feb 20237:00 amRNSUpdate on investment in Hudson MX
1st Feb 20232:10 pmRNSTotal Voting Rights
25th Jan 20237:00 amRNSTrading update and conclusion of strategic review
7th Dec 202212:17 pmRNSHolding(s) in Company
1st Dec 202212:04 pmRNSTotal Voting Rights
21st Nov 202211:53 amRNSHolding(s) in Company
17th Nov 20221:36 pmRNSHolding(s) in Company
12th Oct 20223:10 pmRNSDirector/PDMR Shareholding
11th Oct 202212:29 pmRNSDirector/PDMR Shareholding
3rd Oct 20229:40 amRNSTotal Voting Rights
15th Sep 202210:42 amRNSExternal Directorship
12th Sep 20227:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.